儿科囊性纤维化症的长期运动能力:现代时代的前景
René Gaupmann1, Laura Stöger1, Klara Schmidthaler1
1Department of Paediatrics, Division of Paediatric Pulmonology, Allergy and Endocrinology, Medical University of Vienna, Vienna, Austria.
在囊性纤维化 (CF) 中,心肺适应性在青春期受损. 然而,用elexacaftor,tezacaftor和ivacaftor (ETI) 治疗显著改善了CF的年轻人的氧气吸收峰值.
科学领域:
- 心脏病学 心脏病学
- 肺部病理学 肺部病理学
- 儿科 儿科 儿科
背景情况:
- 对于患有囊性纤维化 (CF) 的人来说,心肺健康至关重要.
- 关于年轻CF患者的健康状况演变的数据有限,特别是新疗法.
- 最近的进展包括elexacaftor,tezacaftor和ivacaftor (ETI) 以及COVID-19的流行病.
研究的目的:
- 调查CF的年轻人运动测试结果的纵向趋势.
- 评估ETI和COVID-19大流行对这些趋势的影响.
主要方法:
- 70名患有CF的年轻人 (12-20岁) 的回顾性观察研究.
- 从2010年到2024年对177个心肺运动测试 (CPET) 的分析.
- 使用混合模型分析的峰值氧气吸收 (V'O2峰值),最大工作负载和通风的纵向趋势.
主要成果:
- 没有ETI的CF患者的VO2峰值低于参考数据.
- 启动ETI显著改善了VO2峰值.
- 通风和最大工作负载没有受到ETI的显著影响.
- 虽然COVID-19大流行与ETI无知的患者的V'O2峰值急剧下降相吻合,但并没有否定ETI的积极影响.
结论:
- 在患有CF的青少年中,心肺健康进展受损.
- 在年轻的CF患者中,ETI治疗对VO2峰的纵向轨迹产生了积极的影响.
更多相关视频
05:56Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
Published on: August 29, 2025
09:42Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation
Published on: November 8, 2013
相关概念视频
Cystic Fibrosis: Management
Sinus disease and chronic...
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Lung Capacity
Respiratory Capacities
One key metric is the Inspiratory Capacity (IC), which represents the maximum amount of air that can be inhaled with full effort. IC is calculated by summing the tidal volume and inspiratory reserve volume, typically ranging from 2.4 to 3.6 liters.
The Functional Residual Capacity (FRC) represents the air in the...
Respiratory Volumes and Capacities I
Respiratory Volumes and Capacities
